Related Experiment Videos
The pathogenesis of autoimmune diseases
H M Lorenz1, M Herrmann, J R Kalden
1Institute for Clinical Immunology, Department of Medicine III, University of Erlangen-Nuremberg, Erlangen, Germany. Hannes.Lorenz@med3.imed.uni-erlangen.de
Summary
This review explores the complex pathogenesis of autoimmune diseases, focusing on rheumatoid arthritis (RA) and Systemic Lupus Erythematosus (SLE). It highlights current understanding and ongoing research into inflammatory cascades and cellular roles in these chronic conditions.
Area of Science:
- Immunology
- Pathology
- Rheumatology
Background:
- Autoimmune diseases are chronic inflammatory conditions with diverse clinical presentations and organ involvements.
- The precise pathogenesis of common autoimmune diseases like rheumatoid arthritis (RA) and Systemic Lupus Erythematosus (SLE) remains incompletely understood.
- While some autoantigens are known in rare diseases, frequent conditions like RA and SLE have only partially elucidated pathogenetic mechanisms.
Purpose of the Study:
- To review and discuss current pathogenetic concepts of autoimmune diseases.
- To focus on rheumatoid arthritis (RA) and Systemic Lupus Erythematosus (SLE) as exemplars.
- To explore the roles of T-lymphocytes, synovial fibroblasts, cytokines, and apoptosis in disease development.
Main Methods:
- Review of existing literature and experimental data.
- Analysis of pathogenetic scenarios in RA and SLE.
- Discussion of controversial aspects in disease initiation and perpetuation.
Main Results:
- Tumor Necrosis Factor-alpha (TNF-alpha) and related cytokines are implicated in the perpetuation of inflammatory cascades in RA.
- Specific blockade of TNF-alpha demonstrates therapeutic efficacy in RA, reducing disease activity and preventing tissue destruction.
- A hypothesis suggests dysregulated apoptosis plays a central role in the development of SLE.
Conclusions:
- Understanding the pathogenetic mechanisms of RA and SLE is crucial for developing effective treatments.
- TNF-alpha blockade offers a targeted approach for managing RA.
- Further research into apoptosis dysregulation is warranted for SLE.